Dr. Vorobiof on the Impact of Financial Toxicity in the Field of Oncology

December 16, 2020
Daniel A. Vorobiof, MD

Daniel A. Vorobiof, MD, the chief medical director of Belong.Life, discusses the impact of financial toxicity on patients with cancer.

Daniel A. Vorobiof, MD, the chief medical director of Belong.Life, discusses the impact of financial toxicity on patients with cancer.

Financial toxicity has become a growing concern for several patients with cancer, as well as their caregivers, says Vorobiof. As treatment costs continue to rise, Vorobiof says that financial toxicity is a challenge that can no longer be ignored. A cancer diagnosis is often accompanied by substantial financial burden, and although this is not a new issue, it must be addressed, Vorobiof says.

Real-world data from several clinical studies indicate that financial toxicity is a major factor that impacts outcomes and the quality of life of patients, spanning different tumor types and treatments received, Vorobiof concludes.


x